News

The Gourdie laboratory had a problem of its own making. The lab at the Fralin Biomedical Research Institute at VTC has spent ...
Pharmacovigilance evolves with technology, employing active surveillance to detect drug-related issues and ensure safety in an increasingly complex landscape.
Half of the patients treated with first-line biologic DMARDs achieved sustained, event-free remission compared with 12% of ...
Women with psoriasis show shorter drug survival for biologics, including IL-17/23 inhibitors, due to lower satisfaction and ...
Medicare will generally help cover the cost of psoriasis medications. Learn more about eligibility for coverage and cost.
Adverse events from disease-modifying antirheumatic drugs for the treatment of rheumatoid arthritis decline by as much as 25% after the drugs are established on the market, according to data published ...
Find out about how biotech is done in space through the example of Exobiosphere and its €2 million seed round.
Although HHS says it did not target FDA product reviewers or inspectors, FDA employees who assist with reviews in various capacities were let go, including project managers and staff in administration ...
One of the worst complications of adult-onset Still's disease is macrophage activation syndrome (MAS), which can be fatal. In ...
Two phase 2 trials with different selective TYK2 inhibitors produce high rates of efficacy in moderate to severe plaque ...
The Inflation Reduction Act was intended to lower prescription drug costs, but an unintended consequence is threatening the ...
The Icahn School of Medicine at Mount Sinai has launched the AI Small Molecule Drug Discovery Center, a bold endeavor that harnesses artificial intelligence (AI) to revolutionize drug development.